Viewing Study NCT01169532


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-05-27 @ 11:58 AM
Study NCT ID: NCT01169532
Status: COMPLETED
Last Update Posted: 2021-02-21
First Post: 2010-07-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
Sponsor: Fox Chase Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 09-034
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View